AtriCure Announces Results from CONVERGE IDE Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. ZM
4. SMTC
5. SPY
6. NCNO
7. META
8. JAZZ
9. BOX
10. NVDA

Go back to AtriCure Announces Results from CONVERGE IDE Clinical Trial
AtriCure, Inc. (NASDAQ: ATRC) Delayed: 47.40 -1.28 (2.63%)
Previous Close $48.68    52 Week High $23.24 
Open $48.02    52 Week Low $13.44 
Day High $48.50    P/E N/A 
Day Low $47.28    EPS $-0.45 
Volume 67,620